IgA腎病牛津病理分型與疾病進(jìn)展的相關(guān)性分析
[Abstract]:Objective to evaluate the risk factors of renal dysfunction in patients with Ig A nephropathy and the correlation between the proportion of crescents and the progression of the disease. Methods A retrospective analysis of 405 patients with Ig A nephropathy in Shenzhen second people's Hospital was performed. The follow-up time was more than 12 months. Pathological indices according to Oxford classification include Mesangial cell proliferation, (M), intracapillary cell proliferation, (E), segmental sclerosis or balloon adhesion, (S), tubular atrophy or interstitial fibrosis (T), Inclusion of cellular or cell-fibrous crescent (C). At the same time The combined endpoints of end stage renal disease, creatinine doubling or 50% reduction of e GFR were used to investigate the correlation between MMA SMC and the progression of the disease. Results (1) General data: 48.1% of 405 patients were female, most of them had occult onset (80.7%), 60.5% had tonsillar enlargement, and the mean arterial pressure (MAP) was 99 鹵14mm Hg,. The 24 hour urinary protein quantification was 1.1 (0.06-14.6) g / d, and the median follow-up time was 39 months. 8.2% of the patients entered the ESRD. (2) pathological index. The ratio of S1 to S 1 was 85.9 and 35.30.The ratio of T 1 and T 2 was 18. 3 and 11. 1, respectively. 236 cases (58.3%) were associated with crescents, of which C 1 and C 2 accounted for 48. 2%, respectively. (2) the level of urinary protein was significantly correlated with the level of Tc, and the level of MAP was significantly correlated with the level of Tc, and the level of Tc was significantly correlated with the level of urinary protein, and the level of Tc was significantly correlated with that of MAP. C and e GFR decreased significantly. (3) there was a positive correlation between Mesangial cell proliferation (M) and RAS blocker therapy, but no significant correlation with glucocorticoid and immunosuppressive therapy. The results suggest that Mesangial proliferation is not the basis for doctors to choose glucocorticoid and immunosuppressant therapy. There was a positive correlation between interstitial fibrosis (T) and crescentin formation of (E), and glucocorticoid and immunosuppressive therapy (er: r = 0.2223 0.254, respectively). S: r = 0.129 / 0.208 / T: r = 0.173 / 0.291, respectively; C: r was 0.21 / 0.249, respectively, in which E and S were not significantly correlated with RAS blockers, while T and C were negatively correlated with RAS blockers (r-0.176), suggesting endothelial cell proliferation and focal segmental sclerosis. Interstitial fibrosis and crescent formation are important evidence for doctors to select glucocorticoids and immunosuppressants. However, the degree of interstitial fibrosis and crescent formation were often the basis of careful use of RAS blockers. (3) risk factors for renal impairment in) Ig AN showed that hypertension, hyperuricemia, and Oxford classification were the pathological markers. T was an independent risk factor for renal dysfunction, while albumin and high density lipoprotein might be protective factors for renal dysfunction. (4) Kaplan-Meier survival curve showed that Kaplan-Meier was associated with the progression of the disease, but MKaplan-Meier was not associated with the progression of the disease. Only T was an independent risk factor for disease progression after univariate and multivariate Cox regression. Conclusion (1) (T) of interstitial fibrosis or tubule atrophy in Oxford classification is an independent predictor of disease progression of Ig AN. (2) segmental sclerosis or balloon adhesion (S),. The ratio of (C) formation in crescents was closely related to the progression of Ig A nephropathy. (3) the level of urinary protein was significantly correlated with the pathological index of Oxford typing, and MAP had a significant correlation with the pathological index EtoS T, and the rate of crescent formation was closely related to the progression of Ig A nephropathy. E GFR has a significant correlation with the pathological marker Scanner C. (4) (E), focal segmental sclerosis (S), of endothelial cell proliferation The formation of interstitial fibrosis (T) and crescents (C) is an important basis for doctors to select glucocorticoids and immunosuppressants in the treatment of Ig A nephropathy. However, the degree of interstitial fibrosis and crescent formation are often the basis of careful use of RAS blockers. (5) Hypertension, hyperuricemia, Oxford type pathological index SfT are the independent risk factors for renal dysfunction, albumin. High density lipoprotein is a protective factor for renal dysfunction.
【學(xué)位授予單位】:安徽醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類(lèi)號(hào)】:R692.31
【參考文獻(xiàn)】
相關(guān)期刊論文 前7條
1 彭用華;蘇穎;趙亞娟;林春妮;孫桂芳;李航;于陽(yáng);黃慶元;葉葳;李雪梅;李學(xué)旺;;IgA腎病牛津分型在腎臟預(yù)后評(píng)價(jià)中的應(yīng)用[J];中國(guó)醫(yī)學(xué)科學(xué)院學(xué)報(bào);2013年01期
2 欒韶東;宋海英;何永成;萬(wàn)啟軍;許慧麗;徐藝;;150例原發(fā)性IgA腎病臨床回顧性分析[J];中國(guó)中西醫(yī)結(jié)合腎病雜志;2012年06期
3 樂(lè)偉波;梁少珊;鄧康平;胡煬琳;曾彩虹;劉志紅;;1126例中國(guó)漢族成人IgA腎病患者的長(zhǎng)期預(yù)后及危險(xiǎn)因素分析[J];腎臟病與透析腎移植雜志;2011年02期
4 劉虹;彭佑銘;劉伏友;楊新民;任基浩;劉映紅;許向青;;扁桃體摘除治療57例IgA腎病的病例對(duì)照研究[J];中華腎臟病雜志;2009年01期
5 何靈芝;馬紅珍;張小云;;120例IgA腎病臨床表現(xiàn)與病理特點(diǎn)分析[J];中國(guó)中西醫(yī)結(jié)合腎病雜志;2008年01期
6 張馨;黎磊石;孫驊;鮑浩;陳惠萍;曾彩虹;鄭春霞;劉志紅;;不同類(lèi)型IgA腎病的流行病學(xué)及臨床特點(diǎn)分析[J];腎臟病與透析腎移植雜志;2006年04期
7 王景福,鄒建洲,丁小強(qiáng),滕杰,宦金星,鐘一紅;IgA腎病86例臨床和病理分析[J];中國(guó)臨床醫(yī)學(xué);2004年04期
,本文編號(hào):2425763
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/2425763.html